Gluten Technology and Education for Celiac Health

Launched by COLUMBIA UNIVERSITY · Sep 22, 2023

Keywords

ClinConnect Summary

This clinical trial, named "Gluten Technology and Education for Celiac Health," is looking at how new gluten detection tools can help manage celiac disease in adults who have recently been diagnosed. Celiac disease is a condition where eating gluten—a protein found in wheat, barley, and rye—can cause serious health problems. The study aims to see if using these detection technologies alongside telemedicine (healthcare provided through phone or video calls) can lead to better recovery of the intestines and improve long-term health monitoring for those with the disease.

To participate in this study, you need to be between 18 and 75 years old and have been diagnosed with celiac disease within the last four months. You should also be willing to use the new gluten detection technology and have already met with a dietitian at one of the study centers. Unfortunately, if you are currently pregnant or not planning to follow a gluten-free diet, you would not be eligible to join. If you take part, you can expect to use the new technology to help manage your condition and receive guidance through telemedicine, all aimed at improving your health and well-being.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Any gender; Age 18-75 years
• • Celiac disease diagnosis by serology and duodenal biopsy (corresponding to •Marsh 3 histology), adequate sampling and interpretable villus height to crypt depth ratio upon review by our study pathologist
• • Diagnosed with celiac disease within 4 months of initial study screening
• • Willingness to use gluten-detection technology
• • Not currently using a gluten detection technology that tests for gluten in urine or stool
• • Seeing a clinician at one of the four recruitment sites
• • Having already had an initial dietitian visit at one of the participating celiac disease centers
• Exclusion Criteria:
• • Currently pregnant or planning to become pregnant during the study
• • Not planning to follow a gluten-free diet
• • Concurrent participation in a clinical trial of an experimental pharmacologic agent (for any condition).